TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

2022-2027 Global and Regional Genitourinary Drugs Industry Status and Prospects Professional Market Research Report Standard Version

2022-2027 Global and Regional Genitourinary Drugs Industry Status and Prospects Professional Market Research Report Standard Version

  • Category:Life Sciences
  • Published on : 08 September 2022
  • Pages :154
  • Formats:
  • Report Code:SMR-7339178
OfferClick for best price

Best Price: $2800

2027 Genitourinary Drugs Market Size, Share 2022


The global Genitourinary Drugs market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market Vendors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

By Market Vendors:

Novartis AG

Genentech

By Types:

Urologicals

Hormonal Therapy

Gynecological

Anti-infectives

By Applications:

Prostate Cancer

Ovarian Cancer

Bladder Cancer

Cervical Cancer

Renal Cancer

Erectile Dysfunction

Urinary Tract Infections

Urinary Incontinence & Overactive Bladder

Sexually Transmitted Diseases

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Report Attributes Report Details
Report Title 2022-2027 Global and Regional Genitourinary Drugs Industry Status and Prospects Professional Market Research Report Standard Version
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 154 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Genitourinary Drugs Market Size Analysis from 2022 to 2027

1.5.1 Global Genitourinary Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Genitourinary Drugs Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Genitourinary Drugs Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Genitourinary Drugs Industry Impact

Chapter 2 Global Genitourinary Drugs Competition by Types, Applications, and Top Regions and Countries

2.1 Global Genitourinary Drugs (Volume and Value) by Type

2.1.1 Global Genitourinary Drugs Consumption and Market Share by Type (2016-2021)

2.1.2 Global Genitourinary Drugs Revenue and Market Share by Type (2016-2021)

2.2 Global Genitourinary Drugs (Volume and Value) by Application

2.2.1 Global Genitourinary Drugs Consumption and Market Share by Application (2016-2021)

2.2.2 Global Genitourinary Drugs Revenue and Market Share by Application (2016-2021)

2.3 Global Genitourinary Drugs (Volume and Value) by Regions

2.3.1 Global Genitourinary Drugs Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Genitourinary Drugs Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Genitourinary Drugs Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Genitourinary Drugs Consumption by Regions (2016-2021)

4.2 North America Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

4.10 South America Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Genitourinary Drugs Market Analysis

5.1 North America Genitourinary Drugs Consumption and Value Analysis

5.1.1 North America Genitourinary Drugs Market Under COVID-19

5.2 North America Genitourinary Drugs Consumption Volume by Types

5.3 North America Genitourinary Drugs Consumption Structure by Application

5.4 North America Genitourinary Drugs Consumption by Top Countries

5.4.1 United States Genitourinary Drugs Consumption Volume from 2016 to 2021

5.4.2 Canada Genitourinary Drugs Consumption Volume from 2016 to 2021

5.4.3 Mexico Genitourinary Drugs Consumption Volume from 2016 to 2021

Chapter 6 East Asia Genitourinary Drugs Market Analysis

6.1 East Asia Genitourinary Drugs Consumption and Value Analysis

6.1.1 East Asia Genitourinary Drugs Market Under COVID-19

6.2 East Asia Genitourinary Drugs Consumption Volume by Types

6.3 East Asia Genitourinary Drugs Consumption Structure by Application

6.4 East Asia Genitourinary Drugs Consumption by Top Countries

6.4.1 China Genitourinary Drugs Consumption Volume from 2016 to 2021

6.4.2 Japan Genitourinary Drugs Consumption Volume from 2016 to 2021

6.4.3 South Korea Genitourinary Drugs Consumption Volume from 2016 to 2021

Chapter 7 Europe Genitourinary Drugs Market Analysis

7.1 Europe Genitourinary Drugs Consumption and Value Analysis

7.1.1 Europe Genitourinary Drugs Market Under COVID-19

7.2 Europe Genitourinary Drugs Consumption Volume by Types

7.3 Europe Genitourinary Drugs Consumption Structure by Application

7.4 Europe Genitourinary Drugs Consumption by Top Countries

7.4.1 Germany Genitourinary Drugs Consumption Volume from 2016 to 2021

7.4.2 UK Genitourinary Drugs Consumption Volume from 2016 to 2021

7.4.3 France Genitourinary Drugs Consumption Volume from 2016 to 2021

7.4.4 Italy Genitourinary Drugs Consumption Volume from 2016 to 2021

7.4.5 Russia Genitourinary Drugs Consumption Volume from 2016 to 2021

7.4.6 Spain Genitourinary Drugs Consumption Volume from 2016 to 2021

7.4.7 Netherlands Genitourinary Drugs Consumption Volume from 2016 to 2021

7.4.8 Switzerland Genitourinary Drugs Consumption Volume from 2016 to 2021

7.4.9 Poland Genitourinary Drugs Consumption Volume from 2016 to 2021

Chapter 8 South Asia Genitourinary Drugs Market Analysis

8.1 South Asia Genitourinary Drugs Consumption and Value Analysis

8.1.1 South Asia Genitourinary Drugs Market Under COVID-19

8.2 South Asia Genitourinary Drugs Consumption Volume by Types

8.3 South Asia Genitourinary Drugs Consumption Structure by Application

8.4 South Asia Genitourinary Drugs Consumption by Top Countries

8.4.1 India Genitourinary Drugs Consumption Volume from 2016 to 2021

8.4.2 Pakistan Genitourinary Drugs Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Genitourinary Drugs Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Genitourinary Drugs Market Analysis

9.1 Southeast Asia Genitourinary Drugs Consumption and Value Analysis

9.1.1 Southeast Asia Genitourinary Drugs Market Under COVID-19

9.2 Southeast Asia Genitourinary Drugs Consumption Volume by Types

9.3 Southeast Asia Genitourinary Drugs Consumption Structure by Application

9.4 Southeast Asia Genitourinary Drugs Consumption by Top Countries

9.4.1 Indonesia Genitourinary Drugs Consumption Volume from 2016 to 2021

9.4.2 Thailand Genitourinary Drugs Consumption Volume from 2016 to 2021

9.4.3 Singapore Genitourinary Drugs Consumption Volume from 2016 to 2021

9.4.4 Malaysia Genitourinary Drugs Consumption Volume from 2016 to 2021

9.4.5 Philippines Genitourinary Drugs Consumption Volume from 2016 to 2021

9.4.6 Vietnam Genitourinary Drugs Consumption Volume from 2016 to 2021

9.4.7 Myanmar Genitourinary Drugs Consumption Volume from 2016 to 2021

Chapter 10 Middle East Genitourinary Drugs Market Analysis

10.1 Middle East Genitourinary Drugs Consumption and Value Analysis

10.1.1 Middle East Genitourinary Drugs Market Under COVID-19

10.2 Middle East Genitourinary Drugs Consumption Volume by Types

10.3 Middle East Genitourinary Drugs Consumption Structure by Application

10.4 Middle East Genitourinary Drugs Consumption by Top Countries

10.4.1 Turkey Genitourinary Drugs Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Genitourinary Drugs Consumption Volume from 2016 to 2021

10.4.3 Iran Genitourinary Drugs Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Genitourinary Drugs Consumption Volume from 2016 to 2021

10.4.5 Israel Genitourinary Drugs Consumption Volume from 2016 to 2021

10.4.6 Iraq Genitourinary Drugs Consumption Volume from 2016 to 2021

10.4.7 Qatar Genitourinary Drugs Consumption Volume from 2016 to 2021

10.4.8 Kuwait Genitourinary Drugs Consumption Volume from 2016 to 2021

10.4.9 Oman Genitourinary Drugs Consumption Volume from 2016 to 2021

Chapter 11 Africa Genitourinary Drugs Market Analysis

11.1 Africa Genitourinary Drugs Consumption and Value Analysis

11.1.1 Africa Genitourinary Drugs Market Under COVID-19

11.2 Africa Genitourinary Drugs Consumption Volume by Types

11.3 Africa Genitourinary Drugs Consumption Structure by Application

11.4 Africa Genitourinary Drugs Consumption by Top Countries

11.4.1 Nigeria Genitourinary Drugs Consumption Volume from 2016 to 2021

11.4.2 South Africa Genitourinary Drugs Consumption Volume from 2016 to 2021

11.4.3 Egypt Genitourinary Drugs Consumption Volume from 2016 to 2021

11.4.4 Algeria Genitourinary Drugs Consumption Volume from 2016 to 2021

11.4.5 Morocco Genitourinary Drugs Consumption Volume from 2016 to 2021

Chapter 12 Oceania Genitourinary Drugs Market Analysis

12.1 Oceania Genitourinary Drugs Consumption and Value Analysis

12.2 Oceania Genitourinary Drugs Consumption Volume by Types

12.3 Oceania Genitourinary Drugs Consumption Structure by Application

12.4 Oceania Genitourinary Drugs Consumption by Top Countries

12.4.1 Australia Genitourinary Drugs Consumption Volume from 2016 to 2021

12.4.2 New Zealand Genitourinary Drugs Consumption Volume from 2016 to 2021

Chapter 13 South America Genitourinary Drugs Market Analysis

13.1 South America Genitourinary Drugs Consumption and Value Analysis

13.1.1 South America Genitourinary Drugs Market Under COVID-19

13.2 South America Genitourinary Drugs Consumption Volume by Types

13.3 South America Genitourinary Drugs Consumption Structure by Application

13.4 South America Genitourinary Drugs Consumption Volume by Major Countries

13.4.1 Brazil Genitourinary Drugs Consumption Volume from 2016 to 2021

13.4.2 Argentina Genitourinary Drugs Consumption Volume from 2016 to 2021

13.4.3 Columbia Genitourinary Drugs Consumption Volume from 2016 to 2021

13.4.4 Chile Genitourinary Drugs Consumption Volume from 2016 to 2021

13.4.5 Venezuela Genitourinary Drugs Consumption Volume from 2016 to 2021

13.4.6 Peru Genitourinary Drugs Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Genitourinary Drugs Consumption Volume from 2016 to 2021

13.4.8 Ecuador Genitourinary Drugs Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Genitourinary Drugs Business

14.1 Novartis AG

14.1.1 Novartis AG Company Profile

14.1.2 Novartis AG Genitourinary Drugs Product Specification

14.1.3 Novartis AG Genitourinary Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Genentech

14.2.1 Genentech Company Profile

14.2.2 Genentech Genitourinary Drugs Product Specification

14.2.3 Genentech Genitourinary Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Genitourinary Drugs Market Forecast (2022-2027)

15.1 Global Genitourinary Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Genitourinary Drugs Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

15.2 Global Genitourinary Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Genitourinary Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Genitourinary Drugs Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Genitourinary Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Genitourinary Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Genitourinary Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Genitourinary Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Genitourinary Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Genitourinary Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Genitourinary Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Genitourinary Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Genitourinary Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Genitourinary Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Genitourinary Drugs Consumption Forecast by Type (2022-2027)

15.3.2 Global Genitourinary Drugs Revenue Forecast by Type (2022-2027)

15.3.3 Global Genitourinary Drugs Price Forecast by Type (2022-2027)

15.4 Global Genitourinary Drugs Consumption Volume Forecast by Application (2022-2027)

15.5 Genitourinary Drugs Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology



LIST OF TABLES & FIGURES

Figure Product Picture

Figure North America Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure United States Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Canada Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Mexico Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure East Asia Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure China Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Japan Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure South Korea Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Europe Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Germany Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure UK Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure France Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Italy Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Russia Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Spain Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Netherlands Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Switzerland Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Poland Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure South Asia Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure India Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Pakistan Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Bangladesh Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Southeast Asia Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Indonesia Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Thailand Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Singapore Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Malaysia Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Philippines Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Vietnam Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Myanmar Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Middle East Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Turkey Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Saudi Arabia Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Iran Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure United Arab Emirates Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Israel Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Iraq Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Qatar Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Kuwait Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Oman Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Africa Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Nigeria Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure South Africa Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Egypt Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Algeria Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Algeria Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Oceania Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Australia Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure New Zealand Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure South America Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Brazil Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Argentina Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Columbia Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Chile Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Venezuela Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Peru Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Puerto Rico Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Ecuador Genitourinary Drugs Revenue ($) and Growth Rate (2022-2027)

Figure Global Genitourinary Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume

Figure Global Genitourinary Drugs Market Size Analysis from 2022 to 2027 by Value

Table Global Genitourinary Drugs Price Trends Analysis from 2022 to 2027

Table Global Genitourinary Drugs Consumption and Market Share by Type (2016-2021)

Table Global Genitourinary Drugs Revenue and Market Share by Type (2016-2021)

Table Global Genitourinary Drugs Consumption and Market Share by Application (2016-2021)

Table Global Genitourinary Drugs Revenue and Market Share by Application (2016-2021)

Table Global Genitourinary Drugs Consumption and Market Share by Regions (2016-2021)

Table Global Genitourinary Drugs Revenue and Market Share by Regions (2016-2021)

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Major Manufacturers Capacity and Total Capacity

Table 2016-2021 Major Manufacturers Capacity Market Share

Table 2016-2021 Major Manufacturers Production and Total Production

Table 2016-2021 Major Manufacturers Production Market Share

Table 2016-2021 Major Manufacturers Revenue and Total Revenue

Table 2016-2021 Major Manufacturers Revenue Market Share

Table 2016-2021 Regional Market Capacity and Market Share

Table 2016-2021 Regional Market Production and Market Share

Table 2016-2021 Regional Market Revenue and Market Share

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table Global Genitourinary Drugs Consumption by Regions (2016-2021)

Figure Global Genitourinary Drugs Consumption Share by Regions (2016-2021)

Table North America Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

Table East Asia Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

Table Europe Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

Table South Asia Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

Table Southeast Asia Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

Table Middle East Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

Table Africa Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

Table Oceania Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

Table South America Genitourinary Drugs Sales, Consumption, Export, Import (2016-2021)

Figure North America Genitourinary Drugs Consumption and Growth Rate (2016-2021)

Figure North America Genitourinary Drugs Revenue and Growth Rate (2016-2021)

Table North America Genitourinary Drugs Sales Price Analysis (2016-2021)

Table North America Genitourinary Drugs Consumption Volume by Types

Table North America Genitourinary Drugs Consumption Structure by Application

Table North America Genitourinary Drugs Consumption by Top Countries

Figure United States Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Canada Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Mexico Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure East Asia Genitourinary Drugs Consumption and Growth Rate (2016-2021)

Figure East Asia Genitourinary Drugs Revenue and Growth Rate (2016-2021)

Table East Asia Genitourinary Drugs Sales Price Analysis (2016-2021)

Table East Asia Genitourinary Drugs Consumption Volume by Types

Table East Asia Genitourinary Drugs Consumption Structure by Application

Table East Asia Genitourinary Drugs Consumption by Top Countries

Figure China Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Japan Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure South Korea Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Europe Genitourinary Drugs Consumption and Growth Rate (2016-2021)

Figure Europe Genitourinary Drugs Revenue and Growth Rate (2016-2021)

Table Europe Genitourinary Drugs Sales Price Analysis (2016-2021)

Table Europe Genitourinary Drugs Consumption Volume by Types

Table Europe Genitourinary Drugs Consumption Structure by Application

Table Europe Genitourinary Drugs Consumption by Top Countries

Figure Germany Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure UK Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure France Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Italy Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Russia Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Spain Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Netherlands Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Switzerland Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Poland Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure South Asia Genitourinary Drugs Consumption and Growth Rate (2016-2021)

Figure South Asia Genitourinary Drugs Revenue and Growth Rate (2016-2021)

Table South Asia Genitourinary Drugs Sales Price Analysis (2016-2021)

Table South Asia Genitourinary Drugs Consumption Volume by Types

Table South Asia Genitourinary Drugs Consumption Structure by Application

Table South Asia Genitourinary Drugs Consumption by Top Countries

Figure India Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Pakistan Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Bangladesh Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Southeast Asia Genitourinary Drugs Consumption and Growth Rate (2016-2021)

Figure Southeast Asia Genitourinary Drugs Revenue and Growth Rate (2016-2021)

Table Southeast Asia Genitourinary Drugs Sales Price Analysis (2016-2021)

Table Southeast Asia Genitourinary Drugs Consumption Volume by Types

Table Southeast Asia Genitourinary Drugs Consumption Structure by Application

Table Southeast Asia Genitourinary Drugs Consumption by Top Countries

Figure Indonesia Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Thailand Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Singapore Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Malaysia Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Philippines Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Vietnam Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Myanmar Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Middle East Genitourinary Drugs Consumption and Growth Rate (2016-2021)

Figure Middle East Genitourinary Drugs Revenue and Growth Rate (2016-2021)

Table Middle East Genitourinary Drugs Sales Price Analysis (2016-2021)

Table Middle East Genitourinary Drugs Consumption Volume by Types

Table Middle East Genitourinary Drugs Consumption Structure by Application

Table Middle East Genitourinary Drugs Consumption by Top Countries

Figure Turkey Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Saudi Arabia Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Iran Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure United Arab Emirates Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Israel Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Iraq Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Qatar Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Kuwait Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Oman Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Africa Genitourinary Drugs Consumption and Growth Rate (2016-2021)

Figure Africa Genitourinary Drugs Revenue and Growth Rate (2016-2021)

Table Africa Genitourinary Drugs Sales Price Analysis (2016-2021)

Table Africa Genitourinary Drugs Consumption Volume by Types

Table Africa Genitourinary Drugs Consumption Structure by Application

Table Africa Genitourinary Drugs Consumption by Top Countries

Figure Nigeria Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure South Africa Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Egypt Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Algeria Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Algeria Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Oceania Genitourinary Drugs Consumption and Growth Rate (2016-2021)

Figure Oceania Genitourinary Drugs Revenue and Growth Rate (2016-2021)

Table Oceania Genitourinary Drugs Sales Price Analysis (2016-2021)

Table Oceania Genitourinary Drugs Consumption Volume by Types

Table Oceania Genitourinary Drugs Consumption Structure by Application

Table Oceania Genitourinary Drugs Consumption by Top Countries

Figure Australia Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure New Zealand Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure South America Genitourinary Drugs Consumption and Growth Rate (2016-2021)

Figure South America Genitourinary Drugs Revenue and Growth Rate (2016-2021)

Table South America Genitourinary Drugs Sales Price Analysis (2016-2021)

Table South America Genitourinary Drugs Consumption Volume by Types

Table South America Genitourinary Drugs Consumption Structure by Application

Table South America Genitourinary Drugs Consumption Volume by Major Countries

Figure Brazil Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Argentina Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Columbia Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Chile Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Venezuela Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Peru Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Puerto Rico Genitourinary Drugs Consumption Volume from 2016 to 2021

Figure Ecuador Genitourinary Drugs Consumption Volume from 2016 to 2021

Novartis AG Genitourinary Drugs Product Specification

Novartis AG Genitourinary Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Genentech Genitourinary Drugs Product Specification

Genentech Genitourinary Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Figure Global Genitourinary Drugs Consumption Volume and Growth Rate Forecast (2022-2027)

Figure Global Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Table Global Genitourinary Drugs Consumption Volume Forecast by Regions (2022-2027)

Table Global Genitourinary Drugs Value Forecast by Regions (2022-2027)

Figure North America Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure North America Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure United States Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure United States Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Canada Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Canada Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Mexico Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Mexico Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure East Asia Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure East Asia Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure China Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure China Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Japan Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Japan Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure South Korea Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure South Korea Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Europe Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Europe Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Germany Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Germany Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure UK Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure UK Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure France Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure France Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Italy Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Italy Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Russia Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Russia Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Spain Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Spain Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Netherlands Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Netherlands Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Swizerland Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Swizerland Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Poland Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Poland Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure South Asia Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure South Asia a Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure India Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure India Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Pakistan Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Pakistan Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Bangladesh Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Bangladesh Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Southeast Asia Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Southeast Asia Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Indonesia Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Indonesia Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Thailand Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Thailand Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Singapore Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Singapore Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Malaysia Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Malaysia Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Philippines Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Philippines Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Vietnam Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Vietnam Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Myanmar Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Myanmar Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Middle East Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Middle East Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Turkey Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Turkey Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Saudi Arabia Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Saudi Arabia Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Iran Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Iran Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure United Arab Emirates Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure United Arab Emirates Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Israel Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Israel Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Iraq Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Iraq Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Qatar Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Qatar Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Kuwait Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Kuwait Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Oman Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Oman Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Africa Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Africa Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Nigeria Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Nigeria Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure South Africa Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure South Africa Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Egypt Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Egypt Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Algeria Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Algeria Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Morocco Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Morocco Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Oceania Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Oceania Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Australia Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Australia Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure New Zealand Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure New Zealand Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure South America Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure South America Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Brazil Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Brazil Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Argentina Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Argentina Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Columbia Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Columbia Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Chile Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Chile Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Venezuela Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Venezuela Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Peru Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Peru Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Puerto Rico Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Puerto Rico Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Figure Ecuador Genitourinary Drugs Consumption and Growth Rate Forecast (2022-2027)

Figure Ecuador Genitourinary Drugs Value and Growth Rate Forecast (2022-2027)

Table Global Genitourinary Drugs Consumption Forecast by Type (2022-2027)

Table Global Genitourinary Drugs Revenue Forecast by Type (2022-2027)

Figure Global Genitourinary Drugs Price Forecast by Type (2022-2027)

Table Global Genitourinary Drugs Consumption Volume Forecast by Application (2022-2027)





REPORT PURCHASE OPTIONS

USD Single User
USD Department License
USD Corporate/Global Licence

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount